Drug repositioning in pulmonary arterial hypertension: challenges and opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities

Published:2019-01 Issue:1 Volume:9 Page:1-18
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Grinnan Daniel¹,Trankle Cory²,Andruska Adam³⁴,Bloom Bruce⁵,Spiekerkoetter Edda³⁴

Affiliation:

1. Department of MedicineDivision of Pulmonary and Critical Care MedicineVirginia Commonwealth UniversityRichmondVAUSA

2. Department of MedicineDivision of CardiologyVirginia Commonwealth UniversityRichmondVAUSA

3. Department of MedicineDivision of Pulmonary and Critical Care MedicineStanford UniversityStanfordCAUSA

4. Wall Center for Pulmonary Vascular DiseaseStanfordCAUSA

5. Cures Within ReachChicagoILUSA

Funder

U.S. Department of Defense

National Center for Research Resources

Pulmonary Hypertension Association

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894019832226

Reference143 articles.

1. Epidemiology and treatment of pulmonary arterial hypertension;Lau EMT;Nat Rev Cardiol,2017

2. Molecular pathogenesis of pulmonary arterial hypertension;Rabinovitch M;J Clin Invest,2012

3. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation;Thenappan T;Eur Respir J,2010

4. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry;Badesch DB;Chest,2010

5. Developing treatments for pulmonary arterial hypertension;Wilkins MR;Pulm Circ,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prospect and Challenges of Repurposing Established Drugs in Pulmonary Arterial Hypertension;BioChem;2024-09-10

2. Exosomes enriched by miR-429-3p derived from ITGB1 modified Telocytes alleviates hypoxia-induced pulmonary arterial hypertension through regulating Rac1 expression;Cell Biology and Toxicology;2024-05-20

3. Methodologies Adopted in Drug Repurposing;Drug Repurposing;2024

4. Endothelial cell senescence exacerbates pulmonary hypertension by inducing juxtacrine Notch signaling in smooth muscle cells;iScience;2023-05

5. Emerging biologics for the treatment of pulmonary arterial hypertension;Journal of Drug Targeting;2023-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3